Market-moving stories, structured for trading automations. Plug into Claude Desktop, Cursor, or your own agent in minutes.
"Claude, what moved NVDA today?"
alphai_news_search → MCP
Try it"Send only high-relevance earnings news for my watchlist."
/api/news/?category=earnings · min_relevance=7
Try it"Build a Telegram bot for market-moving news in 10 minutes."
/api/news/trending/ + your bot framework
Try it"Any insider buying in my watchlist this week?"
alphai_insider_news → MCP · /api/news/insider/
Try it"Feed my agent relevance-scored financial news via MCP."
OAuth 2.1 · 11 tools · Streamable HTTP
Try itOddity Tech (Nasdaq: ODD), parent of Il Makiage, saw its shares peak at a $4.3 billion market cap about a year ago, then fall 86% to about $630 million after a February disruption at its main ad partner, which raised customer acquisition costs and cut revenue. The company withheld annual guidance, citing uncertainty. Analysts remain neutral, with Jefferies calling it a “show me” story.
OpenAI confidentially filed IPO registration statements with the SEC on June 8, but said timing is undecided and could be “a while,” according to the company. Microsoft holds a 27% stake after adding $12 billion, and receives 20% of OpenAI revenue through 2030 (up to $38 billion). The article also notes Microsoft’s $250 billion Azure spending commitment through 2032.
On June 7, Keefe Bruyette downgraded Allstate (NYSE:ALL) to Market Perform from Outperform and cut its price target to $242 from $266, citing that year-over-year personal auto policies in force growth peaked in February. Analyst Meyer Shields said intensifying rate competition could limit reacceleration. Allstate will stop monthly PIF reporting after May but will continue quarterly PIF growth reporting; it reported Q1 2026 revenue of $16.9 billion and net income of $2.4 billion.
Poolbeg Pharma, a London startup, said it will trial its oral drug POLB 001 at six NHS hospitals to prevent cytokine release syndrome (CRS) in patients receiving blood cancer immunotherapy. The trial will enroll 30 people treated with Johnson & Johnson’s teclistamab (Tecvayli), led by the University of Manchester and Christie NHS Foundation Trust. Poolbeg expects interim data by end of summer; it estimates a $10bn market potential at $20,000 per treatment.
Elon Musk became the world’s first trillionaire as SpaceX’s Nasdaq IPO drove a surge in the company’s shares. SpaceX priced at $135, opened at $150, and briefly hit $176.50; it closed around $161. The IPO raised about $75bn and valued SpaceX at $2.2tn, with Musk holding 42%. Bloomberg put Musk’s net worth at $1.11tn.
Pfizer said the U.S. FDA approved an expanded indication for Hympavzi on June 8, 2026, extending use to hemophilia A or B patients aged 12+ with inhibitors and pediatric patients with or without inhibitors, and adding routine prophylaxis for certain adults and children 6+. On June 7, Pfizer presented Phase 2b results for berobenatide. On May 31, it reported Breakwater Phase 3 Cohort 3 data, with median progression-free survival nearly doubled for BRAFTOVI vs comparator.
On June 8, 2026, JPMorgan raised its UnitedHealth Group (UNH) price target to $466 from $420 and kept an Overweight rating, citing updated healthcare service models. Mizuho raised its target to $460 from $440 with an Outperform rating, saying policy surprises may moderate. Separately, BofA upgraded UNH to Buy and set a $450 target from $420.
The same relevance-scored news feed that powers alphai is available as a REST API and as an MCP server for Claude Desktop, Cursor, and any agent host. Ticker-linked, real-time enrichment.
curl https://api.alphai.io/api/news/ \
-H "Authorization: Bearer ${ALPHAI_API_KEY}" \
-G -d "symbol=NVDA"
# → {
# "results": [{
# "original": {
# "title": "Nvidia export curbs tighten...",
# "summary": "The White House is expected to...",
# "time_published": "2026-04-18T14:32:00Z"
# },
# "enrichment": {
# "category": "macro",
# "tickers": ["NVDA"],
# "relevance_score": 9
# }
# }, ...],
# "next_cursor": "MjAyNi0wNC0xOFQxNDozMjowMHw0Mg=="
# }Free reads the feed and probes the APIs. Paid plans drop the ads and scale up the rate.